What we do
Blue bioeconomy has an anticipated high growth rate linked to the existence of important societal needs for products/services that are created by using blue biotechnologies (food, medicines, cosmetics, tourism/leisure, biofuels, environment etc.). Beside this, investments in R&I may support the revitalisation of traditional sectors (i.e. fishery) and the development of emerging ones (i.e. marine aquaculture). There is a growing consensus at different levels of government - Agenda 2030, European Green Deal, national and regional strategies - recognising the urgency of a sustainable transition transformation. This is true also in the blue economy field that faces growing challenges primarily due to marine environment contamination and climate change that alter marine biosystems.
Environmental sustainability is a condition for the enhancement of blue bioeconomy to be dealt jointly with economic and social challenges linked to global competition, dignitous work and territorial disparities. R&I is a key asset to lead the transition toward sustainable development, but the innovation performance in MED area is below EU average, with internal diversity that can be exploited for win-win interregional cooperation. Existing assets would benefit from upscaling initiatives, joint investments to reach critical mass and cooperation across borders to exploit smart complementarities.
A new innovation policy paradigm is emerging. New narratives and governance models to address complex challenges are necessary, also to overcome the fragmentation of existing multiple policy frameworks and not interoperable funding sources (H2020, EMFF, ERDF, ESF, EU investment plans, etc.) usually known only within the specialised communities. At the same time, at MED level there is a long history and practice of cooperation and a number of governance frameworks already in place that contribute to compose interests and priorities (UfM, UNEP/MAP, macroregional and sea basin strategies, Bluemed).
Blue Bio Med will create synergies with past or current EU and other projects and initiatives. The project has been conceived as part of a broader project community. Synergies with other Interreg MED thematic communities with overlapping interests and themes (Biodiversity Protection, Green Growth, etc.) and with other Axis 4 projects will be exploited during the project life.
BLUEBIOMED takes advantage of the output of two recent transnational cooperation projects: MISTRAL (Interreg MED) participated by ART-ER and OIS-AIR (Interreg ADRION) led by Area Science Park. The former developed a methodology to map MED RIS3 blue economy priorities and the Blue Growth Book, containing a state of the art assessment and overview on the most relevant drivers and opportunities in the Mediterranean Blue Economy covering 8 MED countries.
The project will benefit from synergies with the work done by the Bluemed CSA (National Research Council of Italy coordinating the CSA) with a specific reference to the Pilot Action Healthy Plastic-free Mediterranean See that will be the starting point for the Project experiment on this challenge.